Pandorum Technologies
ApplicationBengaluru, IndiaFounded 2011
Bioprinting pioneer creating lab-grown human tissues for drug discovery and regenerative medicine
- CEO / Founder
- Tuhin Bhowmick
- Team Size
- 50-100
- Stage
- Series B funded, pre-revenue stage developing flagship therapy
- Total Funding
- $36.8M
- Latest Round
- Series B
- Key Investors
- Protons Corporate, Ashish Kacholia, Indian Angel Network, 021 Capital, BTB Venture
Technology & Products
Key Products
Engineered liver models, corneal models, Kuragenx "Liquid Cornea" therapy, proprietary bioprinting platform
Technological Advantage
Proprietary bioprinting platform for high-precision tissue engineering
Market & Competition
Target Customers
Pharmaceutical companies, research institutions, hospitals
Industry Verticals
Pharmaceuticals, Biotechnology, Healthcare, Research
Competitors
Organovo, Aspect Biosystems, CELLINK